How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.


Hutchinson MediPharma is looking for collaborations

Organization name

Hutchinson MediPharma


Hutchison MediPharma is an internationally focused biotechnology company focused on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases.

Hutchison MediPharma has entered into drug discovery and development agreements with Johnson & Johnson, Eli Lilly, Merck KGaA and Procter & Gamble. In particular, the partnership between Hutchison MediPharma and Johnson & Johnson marks the largest ever in the Chinese pharmaceutical industry, with upfront and milestone payments of up to $100 million.

Those partnerships validate Hutchison MediPharma's business model and quality of its drug discovery and development.Hutchison MediPharma's collaboration with large pharmaceutical companies represents a new model of innovative drug discovery & development partnerships for the Chinese pharmaceutical R&D industry. This kind of risk/reward and IP sharing model could quickly advance China’s new drug R&D capability to global level.

In addition, Hutchison MediPharma has formed research and strategic collaborations with renowned univerisities and institutes worldwide like the University of California at Los Angeles, the Shanghai Institute of Materia Medica, the Genetic and Cell Biology Institute of North-Eastern Normal University, Hong Kong Chinese University, the University of Maryland and Cambridge University...

We expect these partnerships to provide Hutchison MediPharma with novel drug targets, assays, compound libraries and clinical expertise to further enhance Hutchison MediPharma's research portfolio. Hutchison MediPharma will continue to investigate and discuss other potential alliances with appropriate organizations.

Hutchison MediPharma is seeking opportunities to collaborate with leading universities, research institutes, and pharmaceutical and biotechnology companies in the following areas:

  • Joint drug discovery research
  • Mechanism of Action studies 
  • Joint clinical development
  • In- and out-licensing drug candidates at various stages

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.


latest entries